Jasper Therapeutics, Inc. (JSPR) Insider Trading

Name: Jasper Therapeutics, Inc. (JSPR) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 4, 2026): Thomas G. Wiggans (Director): Grant/Award of 7,500 shares.

Get alerted when insiders trade JSPR

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta